Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000288411

Medchemexpress LLC 1,2,4-triazolo[4,3-b]pyridazine, 3-[(2-methyl-2H-indazol-5-yl)thio]-6-(1-methyl-1H-pyrazol-4-yl)- | 1357072-61-7 | MFCD26960936 | 98.9% | 362.41 g/mol | C17H14N8S | 10 MG
SDP

Supplier:  Medchemexpress LLC HY1573510MG

Encompass_Preferred

c-Met inhibitor 1 is an orally active small-molecule inhibitor of the c-Met (HGFR) receptor tyrosine kinase with reported antitumor activity. It is supplied as a research-grade solid suitable for in vitro and in vivo pharmacology studies.

  • Orally active c-Met kinase inhibitor for preclinical research.
  • Demonstrated antitumor activity in multiple xenograft models.
  • High purity, 98.9% by supplier analysis.
  • Solid powder form suitable for formulation and dosing studies.
  • Identifying data: CAS 1357072-61-7; formula C17H14N8S; MW 362.41 g/mol.
  • Recommended storage: powder at -20°C for long-term, 4°C for short-term.

Catalog No. 50-002-88411


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.